The coexistence of WM and ALL with KMT2D and MECOM mutations have not been reported.<h4>Case presentation</h4>A 74-year-old female patient was diagnosed with WM in July 2018 and received four cycles of chemotherapy of bortezomib and dexamethasone. This evidence concerns the gene MECOM and acute lymphoblastic leukemia.